Pow-Sang J - Search Results

1

Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.

Mendez MH, Passoni NM, Pow-Sang J, Jones JS, Polascik TJ. Mendez MH, et al. J Endourol. 2015 Oct;29(10):1193-8. doi: 10.1089/end.2014.0881. Epub 2015 Jul 13. J Endourol. 2015. PMID: 26058496

2

Enrollment criteria controversies for active surveillance and triggers for conversion to treatment in prostate cancer.

Buethe DD, Pow-Sang J. Buethe DD, et al. J Natl Compr Canc Netw. 2012 Sep;10(9):1101-10. doi: 10.6004/jnccn.2012.0116. J Natl Compr Canc Netw. 2012. PMID: 22956809 Review.

3

High grade prostate intraepithelial neoplasia (PIN) is a PSA-independent risk factor for prostate cancer in African American men: results from a pilot study.

Chornokur G, Han G, Tanner R, Lin HY, Green BL, Pow-Sang J, Phelan CM. Chornokur G, et al. Cancer Lett. 2013 May 1;331(2):154-7. doi: 10.1016/j.canlet.2012.12.014. Epub 2012 Dec 23. Cancer Lett. 2013. PMID: 23268329 Free PMC article.

4

Focal cryotherapy in the treatment of localized prostate cancer.

Nguyen HD, Allen BJ, Pow-Sang JM. Nguyen HD, et al. Cancer Control. 2013 Jul;20(3):177-80. doi: 10.1177/107327481302000305. Cancer Control. 2013. PMID: 23811701 Free article. Review.

5

[Cryosurgery for prostate cancer: a comprehensive review].

Sverrisson E, Jones JS, Pow-Sang JM. Sverrisson E, et al. Arch Esp Urol. 2013 Jul-Aug;66(6):546-56. Arch Esp Urol. 2013. PMID: 23985454 Review. Spanish.

6

Primary cryosurgery for clinically localized prostate cancer--do perioperative tumor characteristics correlate with post-treatment biopsy results?

Sverrisson EF, Nguyen H, Kim T, Pow-Sang JM. Sverrisson EF, et al. Urology. 2014 Feb;83(2):376-8. doi: 10.1016/j.urology.2013.10.018. Epub 2013 Dec 7. Urology. 2014. PMID: 24315311

7

Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.

Li YH, Elshafei A, Agarwal G, Ruckle H, Powsang J, Jones JS. Li YH, et al. Prostate. 2015 Jan;75(1):1-7. doi: 10.1002/pros.22881. Epub 2014 Oct 4. Prostate. 2015. PMID: 25283814

8

Long term survival and predictors of disease reclassification in patients on an active surveillance protocol for prostate cancer.

Agarwal G, Buethe D, Russell C, Luchey A, Pow-Sang JM. Agarwal G, et al. Can J Urol. 2016 Apr;23(2):8215-9. Can J Urol. 2016. PMID: 27085826

9

Predictability of PSA failure in prostate cancer by computerized cytometric assessment of tumoral cell proliferation.

Diaz JI, Mora LB, Austin PF, Muro-Cacho CA, Cantor AB, Nicosia SV, Pow-Sang JM. Diaz JI, et al. Urology. 1999 May;53(5):931-8. doi: 10.1016/s0090-4295(98)00625-6. Urology. 1999. PMID: 10223486

10

Observation in the management of localized prostate cancer.

Hoff B, Pow-Sang JM. Hoff B, et al. Cancer Control. 2001 Mar-Apr;8(2):151-4. doi: 10.1177/107327480100800205. Cancer Control. 2001. PMID: 11326169 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters